
oDocs’ scholarship award
oDocs Eye Care has awarded a postgraduate scholarship to Roger Hu from the Mechatronics Engineering Department in the Faculty of Engineering at the University of Auckland.

oDocs Eye Care has awarded a postgraduate scholarship to Roger Hu from the Mechatronics Engineering Department in the Faculty of Engineering at the University of Auckland.

An eye-movement-based test to measure visual acuity in pre-schoolers developed by researchers at the Auckland Bioengineering Institute has been awarded a $1.2 million Health Research Council (HRC) project grant. The grant will facilitate a trial of the optokinetic nystagmus (OKN) technology at South

Australia’s Department of Health has announced it will follow-up 2016’s inaugural national eye health survey in the coming months.

The Australian Commission on Safety and Quality in Health Care’s (ACSQHC) new Cataract Clinical Care Standard has been rebuffed by the Royal Australian and New Zealand College of Ophthalmologists (RANZCO).

The Warehouse Group (TWG) has taken a stake in Zoom Health, a health technology company and shareholder in Zoom Care, an online pharmacy delivering prescription medicines to patients.

Device Technologies is boosting its ophthalmic diagnostic division with new recruit Regan Clark joining the team.

The International Agency for the Prevention of Blindness (IAPB) has launched its annual development programme to celebrate the world’s Eye Health Heroes.

The theme of the second Ocular Therapeutics Evening (OTE) was anterior segment. Dr Sue Ormonde, the first of four guest speakers, opened by discussing the management of different forms of infective keratitis, emphasising that we should not use topical steroids until we know what we are treating. She

The much-anticipated 52nd Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists (RANZCO) has been postponed to 25 February-1 March 2022, as Victoria, New South Wales and Auckland continue to battle Covid-19.

Diagnostic and subclassification testing of dry eye disease (DED) is particularly important for informing tailored and optimised management plans for patients in clinical practice, as well as for guiding participant recruitment and the evaluation of outcome measures in population-based epidemiology

In recent years there has been growing interest in the potential link between a number of modifiable lifestyle risk factors and the development of dry eye disease, the goal being to inform cost-effective disease prevention strategies at the population level. This is important, since the public healt

Glaukos has announced it ended its patent infringement lawsuit in respect of Ivantis’ Hydrus Microstent, accepting a $60 million payment and 10% royalities until April 2025. Glaukos began legal